At a glance
- Originator Nonindustrial source
- Class Heart failure therapies; Hydrazines; Small molecules; Vasodilators
- Mechanism of Action Nitric oxide donors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure; Ischaemic heart disorders